The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy
Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yousheng Mao(Chinese Academy of Medical Sciences & Peking Union Medical College), Gening Jiang(Tongji University), Hyun Koo Kim(Korea University), Martínez I. Garutti(Fujian Medical University), Zhongmin Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dominique Gossot(Sir Run Run Shaw Hospital), Weimin Mao(St James's University Hospital), Mohsen Ibrahim(Sir Run Run Shaw Hospital), Jin‐Shing Chen(National Taiwan University Hospital), Andrea Imperatori(University of Insubria), John B. Downs(Chinese Academy of Medical Sciences & Peking Union Medical College), Pier Luigi Filosso(University of Turin), Wentao Fang(Shanghai Jiao Tong University), Ying Chai(People's Hospital of Kaizhou District), Seth Force(Emory Healthcare), Qiang Li(Fernández-Vega Ophthalmological Institute), Kevin W. Lobdell, Bo Laksáfoss Holbek(St James's University Hospital), Deruo Liu(Roswell Park Comprehensive Cancer Center), Stephen D. Cassivi(Mayo Clinic), Pierre‐Emmanuel Falcoz(Chinese Academy of Medical Sciences & Peking Union Medical College), David T. Cooke(University of California Davis Medical Center), Lunxu Liu(Sichuan University), Eric Lim(The Francis Crick Institute), Xiangning Fu(Tongji University), Alessandro Brunelli(St James's University Hospital), Javier Aragón(Roswell Park Comprehensive Cancer Center), Zhongheng Zhang(Shaoxing University), Xiaofei Li(Air Force Medical University), Chun Chen(Sun Yat-sen University), Gang Chen(Fudan University), Zhijun Li(Dalian Ocean University), Yin Li(Third Affiliated Hospital of Sun Yat-sen University), Chang Chen(Fujian Medical University), Jie He(First Affiliated Hospital of Jinan University), Gaofeng Li(Sir Run Run Shaw Hospital), Hui Li(Tianjin University), Haiquan Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianxing He(First Affiliated Hospital of Guangzhou Medical University), Yunchao Huang(Kunming Medical University), Danqing Li(Dalian Medical University), Hongjing Jiang(Tianjin Medical University Cancer Institute and Hospital), Mahmoud Ismail(Guangdong General Hospital), Chia-Chuan Liu(National Cheng Kung University), Henrik Jessen Hansen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongyi Liu(China Medical University), Diego González-Rivas(Universidade da Coruña), Haitao Ma(Ningbo University), Jian Hu(National Medical Products Administration)
Cited by 58
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Guidelines for Perioperative Care in Cardiac Surgery
|JAMA Surgery|2019|1.2k
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2023|1k